Can-Fite BioPharma Ltd. (CANF)
NYSEAMERICAN: CANF · IEX Real-Time Price · USD
3.710
+0.190 (5.40%)
Jul 26, 2024, 4:00 PM EDT - Market closed
Can-Fite BioPharma Market Cap
Can-Fite BioPharma has a market cap or net worth of $21.99 million as of July 26, 2024. Its market cap has increased by 171.43% in one year.
Market Cap
21.99M
Enterprise Value
19.56M
1-Year Change
171.43%
Ranking
Category
Stock Price
$3.71
Market Cap Chart
Since December 31, 2012, Can-Fite BioPharma's market cap has decreased from $37.20M to $21.99M, a decrease of -40.90%. That is a compound annual growth rate of -4.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 16.00M | 77.78% |
| Dec 29, 2023 | 9.00M | -46.11% |
| Dec 30, 2022 | 16.70M | -35.52% |
| Dec 31, 2021 | 25.90M | -5.47% |
| Dec 31, 2020 | 27.40M | 522.73% |
| Dec 31, 2019 | 4.40M | -79.05% |
| Dec 31, 2018 | 21.00M | 2.44% |
| Dec 29, 2017 | 20.50M | -37.69% |
| Dec 30, 2016 | 32.90M | 5.79% |
| Dec 31, 2015 | 31.10M | 13.09% |
| Dec 31, 2014 | 27.50M | -41.74% |
| Dec 31, 2013 | 47.20M | 26.88% |
| Dec 31, 2012 | 37.20M | - |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Acasti Pharma | 27.07M |
| Brainstorm Cell Therapeutics | 27.06M |
| Meihua International Medical Technologies Co. | 26.73M |
| SAB Biotherapeutics | 26.67M |
| Beyond Air | 25.80M |
| ATI Physical Therapy | 25.62M |
| Biora Therapeutics | 25.50M |
| NRx Pharmaceuticals | 25.36M |